DEFA1 and COVID-19: The data in our possession show an increase in HNP-1, HBD-1 and HBD-4 in both serum and cord blood of patients with the COVID compared to controls; in addition, the levels of HBD-4, inducible defensin [22], found to be higher in the cord blood taken from pregnant women with COVID-19.